Volume 12, Number 7—July 2006
Letter
Panton-Valentine Leukocidin Genes in Staphylococcus aureus
Table
Amplified fragment length polymorphism cluster |
||||||
---|---|---|---|---|---|---|
I
(n = 462) |
II
(n= 261) |
III
(n = 208) |
IVa
(n = 62) |
IVb
(n = 40) |
Total
(N = 1,033) |
|
PVL positive, n (%) | ||||||
Carriage isolates (n = 829) | 1 | 1 | 1 | 0 | 2 | 5 (0.6)* |
Bacteremia isolates (n = 146) | 1 | 1 | 0 | 0 | 1 | 3 (2.1)† |
Soft tissue infection isolates (n = 18) | 1 | 5 | 0 | 1 | 0 | 7 (38.9)‡ |
Impetigo isolates (n = 40) | 0 | 0 | 0 | 0 | 0 | 0 (0.0) |
Total (N = 1,033) | 3 (0.6)§ | 7 (2.7) | 1 (0.5)¶ | 1 (1.6) | 3 (7.5)# | 15 (1.5) |
MLST** data of PVL-positive isolates | CC 1, n = 2 CC 8, n = 1 | CC 30, n = 7 | CC 45, n = 1 | CC 22, n = 1 | CC 121, n = 3 |
‡versus *Fisher exact test (2-sided); p<0.0001.
‡versus †Fisher exact test (2-sided); p<0.0001.
#versus §Fisher exact test (2-sided); p = 0.0079.
#versus ¶Fisher exact test (2-sided); p = 0.0140.
**MLST, multilocus sequence typing; CC, clonal complex.
Page created: December 16, 2011
Page updated: December 16, 2011
Page reviewed: December 16, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.